CLINICAL_TRIALS trial_result · 2007-06-06

Clinical Trial Update: Study of Treatment High Risk and/or Low Risk Acute Lymphoblastic leukémia(ALL) Adults Stage III [Phase 3]

Phase 3 clinical trial evaluating treatment for adults with high-risk and/or low-risk acute lymphoblastic leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: French Innovative Leukemia Organisation | Conditions: Leukemia, Lymphocytic, Acute | Phase 3 | Status: COMPLETED